Syndax Announces Participation in November Investor Conferences
Syndax Pharmaceuticals announced that CEO Michael A. Metzger and members of the management team will participate in four investor conferences in November 2026. Fireside chats are scheduled at the Guggenheim Healthcare Innovation Conference (Nov 10), Stifel Healthcare Conference (Nov 12), UGS Global Biopharma Conference in London (Nov 17), and Jefferies London Healthcare Conference (Nov 19). Live webcasts and replays will be available in the investor section of the company's website.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.